Evaluates dual SSTR imaging to improve diagnostic accuracy in neuroendocrine tumors versus uterine fibroids, suggesting enhanced therapy planning.
A 22-year-old woman with a neuroendocrine tumor underwent 68Ga-DOTANOC PET/CT, revealing incidental uterine fibroid uptake mimicking pelvic metastasis. The fibroid's hyperavidity posed diagnostic ambiguity, indistinguishable from low-grade NET deposits. Crucially, subsequent 68Ga-NODAGA-JR11 (SSTR antagonist) PET/CT demonstrated preserved tumor detection but absent fibroid uptake, unequivocally confirming benign leiomyoma. This striking discordance unveils agonists' internalization trap-prolonged DOTANOC retention through SSTR2 endocytosis in estrogen-primed fibroids-versus antagonists' precision: surface binding without non-specific accumulation. In fibroids, the lack of antagonist binding-despite agonist positivity-arises from inadequate receptor density to support sustained surface binding, thereby eliminating false-positive results. Dual SSTR imaging redefines diagnostic certainty, averting interventions while optimizing theranostics.
No takes yet. Share an insight, caveat, or question.
Taggar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: